ATB Therapeutics a biopharmaceutical company advancing next-generation antibody-based therapies for oncology and immunology, announced the appointment of Mark Throsby, PhD, as Chief Executive Officer. The...
LOTTE Biologics has its antibody manufacturing deal with Ottimo Pharma, an emerging strategic partner in developing cutting-edge therapies for oncology. The expanded manufacturing collaboration...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Ribbon Bio has recently announced the launch of its cell-free MiroSynth DNA platform, as well as a new in-lab cell-free DNA production kit, providing...
